prostaglandin
Small moleculeexperimental
Prostaglandins (PG) are a group of physiologically active lipid compounds called eicosanoids that have diverse hormone-like effects in animals. Prostaglandins have been found in almost every tissue in humans and other animals. They are derived enzymatically from the fatty acid arachidonic acid. Every prostaglandin contains 20 carbon atoms, including a 5-carbon ring. They are a subclass of eicosanoids and of the prostanoid class of fatty acid derivatives. — Wikipedia
Clinical trial activity
18 trials · 23 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
9
Phase 3
4
Phase 4
4
Earliest trial started Dec 1, 2003 (NCT00200590)
Timeline
Indications
Approved for
Mechanism of action
- Unspecified targetOTHER
Other
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaProstaglandin ↗
Also known as
- prostagladin
- prostaglandin
- prostaglandin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05636904 | Phase 1/Phase 2 (Phase 2) | Dec 5, 2022 | Dermaliq Therapeutics, Inc. |
| NCT05043558 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2022 | Shenzhen University |
| NCT04949633 | Phase 3 | Sep 28, 2021 | University Hospital, Tours |
| NCT05241938 | N/A | Sep 1, 2021 | Federal University of Rio Grande do Sul |
| NCT04891588 | N/A | Mar 8, 2021 | Klinički Bolnički Centar Zagreb, University of Zagreb |
| NCT03758625 | Phase 1 | Nov 30, 2018 | National Institute of Allergy and Infectious Diseases (NIAID), University of Pittsburgh |
| NCT03471858 | N/A | Oct 1, 2018 | Government of Singapore, National University of Singapore |
| NCT03292796 | Phase 2 | Dec 7, 2016 | University of East Anglia |
| NCT02720978 | Phase 3 | May 1, 2016 | Tel Aviv University |
| NCT01704989 | Phase 4 | Oct 1, 2012 | Dalhousie University, Government of Canada, Nova Scotia Health Authority |
| NCT01263444 | Phase 4 | Mar 1, 2011 | Alcon |
| NCT01156012 | Phase 3 | Sep 1, 2009 | Laboratoires Thea |
| NCT01494753 | Phase 2 | Jun 1, 2008 | Laboratoires Thea |
| NCT00546286 | Phase 3 | May 31, 2006 | Merck |
| NCT00572936 | Phase 2 | Nov 1, 2005 | Pfizer, University of Nebraska |
| NCT00822055 | Phase 4 | May 1, 2005 | Allergan |
| NCT00822081 | Phase 4 | Jan 1, 2005 | Allergan, Bp Consulting, Inc |
| NCT00200590 | N/A | Dec 1, 2003 | University of Nantes |
Showing 18 of 18 trials
Page 1 / 1
Organizations
Research & Development (23)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Allergan | For profit | 2 | 1 | 1 | 2005 |
| Laboratoires Thea | For profit | 2 | 2 | 2 | 2008 |
| Alcon | For profit | 1 | 1 | 1 | 2011 |
| Bp Consulting, Inc | For profit | 1 | 1 | 1 | 2005 |
| Dalhousie University | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Dermaliq Therapeutics, Inc. | For profit | 1 | 1 | 1 | 2022 |
| Federal University of Rio Grande do Sul | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Government of Canada | Government | 1 | 0 | 1 | 2012 |
| Government of Singapore | Government | 1 | 1 | 1 | 2018 |
| Klinički Bolnički Centar Zagreb | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Merck | For profit | 1 | 1 | 1 | 2006 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 0 | 1 | 2018 |
| National University of Singapore | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Nova Scotia Health Authority | Academic/Hospital | 1 | 1 | 1 | 2012 |
| Pfizer | For profit | 1 | 0 | 1 | 2005 |
| Shenzhen University | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Tel Aviv University | Academic/Hospital | 1 | 1 | 1 | 2016 |
| University Hospital, Tours | Academic/Hospital | 1 | 1 | 1 | 2021 |
| University of East Anglia | Academic/Hospital | 1 | 1 | 1 | 2016 |
| University of Nantes | Academic/Hospital | 1 | 1 | 1 | 2003 |
23 organizations
Page 1 / 2